SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CAMARDA, Valeria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.527
AS - Asia 1.409
EU - Europa 951
SA - Sud America 180
AF - Africa 20
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 7.090
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.465
SG - Singapore 513
CN - Cina 477
DE - Germania 210
UA - Ucraina 169
GB - Regno Unito 152
BR - Brasile 149
IT - Italia 128
TR - Turchia 126
HK - Hong Kong 106
FI - Finlandia 94
VN - Vietnam 87
SE - Svezia 53
RU - Federazione Russa 39
CA - Canada 35
FR - Francia 28
IN - India 25
JP - Giappone 22
MX - Messico 22
PL - Polonia 18
AR - Argentina 14
NL - Olanda 13
ZA - Sudafrica 12
BE - Belgio 11
ID - Indonesia 11
LT - Lituania 9
ES - Italia 8
BD - Bangladesh 7
IQ - Iraq 6
UZ - Uzbekistan 6
AT - Austria 5
CO - Colombia 5
EC - Ecuador 4
IE - Irlanda 4
PK - Pakistan 4
SA - Arabia Saudita 4
TN - Tunisia 4
BG - Bulgaria 3
IL - Israele 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
BH - Bahrain 2
CZ - Repubblica Ceca 2
IR - Iran 2
JM - Giamaica 2
PY - Paraguay 2
RO - Romania 2
VE - Venezuela 2
AM - Armenia 1
AU - Australia 1
CH - Svizzera 1
CL - Cile 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
GE - Georgia 1
KW - Kuwait 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MY - Malesia 1
NP - Nepal 1
PA - Panama 1
SN - Senegal 1
SV - El Salvador 1
Totale 7.090
Salva come PNG Salva come JPEG
Città #
Dallas 797
Fairfield 475
Woodbridge 431
Ashburn 345
Singapore 317
Houston 252
Jacksonville 188
Seattle 178
Chandler 173
Cambridge 161
Beijing 160
Ann Arbor 139
Santa Clara 137
Wilmington 136
Hong Kong 105
New York 74
Munich 70
Nanjing 64
Izmir 62
Los Angeles 62
San Diego 47
Milan 43
Princeton 40
Boardman 33
Shanghai 33
Helsinki 32
Dong Ket 26
Ho Chi Minh City 26
Turku 26
London 25
Ferrara 24
Dearborn 22
Tokyo 22
Bremen 20
Addison 16
Hebei 16
Mcallen 16
Shenyang 16
São Paulo 15
Brooklyn 14
Mexico City 14
Nanchang 14
Warsaw 13
Auburn Hills 12
Buffalo 12
Hanoi 12
Hefei 12
Montréal 12
Brussels 11
Changsha 10
Orem 10
San Francisco 10
Falkenstein 9
Frankfurt am Main 9
Norwalk 9
Philadelphia 9
Tianjin 9
Atlanta 8
Denver 8
Boston 7
Chennai 7
Jiaxing 7
Jinan 7
Johannesburg 7
Moscow 7
Ningbo 7
Padova 7
Stockholm 7
Bexley 6
Charlotte 6
Manchester 6
Montreal 6
Mountain View 6
New Delhi 6
Rio de Janeiro 6
Toronto 6
Amsterdam 5
Chicago 5
Falls Church 5
Guangzhou 5
Indiana 5
Phoenix 5
Poplar 5
Tappahannock 5
Tashkent 5
Ankara 4
Biên Hòa 4
Bologna 4
Dublin 4
Porto Alegre 4
Querétaro 4
Redwood City 4
Rome 4
San Mateo 4
Augusta 3
Baghdad 3
Carney 3
Curitiba 3
Elk Grove Village 3
Guarulhos 3
Totale 5.251
Salva come PNG Salva come JPEG
Nome #
1,4-Dioxolane-triazaspirodecanone derivatives as nociceptin/orphanin FQ receptor ligands 952
Chimeric G proteins in fluorimetric calcium assays: Experience with opioid receptors 314
A new ligand for the urotensin II receptor 216
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 214
null 205
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4′-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide 204
Conformation-activity relationship of neuropeptide S and some structural mutants: Helicity affects their interaction with the receptor 197
Cell and tissue responses of a range of Urotensin II analogs at cloned and native urotensin II receptors. Evidence for coupling promiscuity 190
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 186
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 185
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24 181
In vitro and in vivo pharmacological characterization of the novel NK(1) receptor selective antagonist Netupitant. 179
Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents 177
Inhibitory effects of putative peptidic urotensin-II receptor antagonists on urotensin-II-induced contraction of cat isolated respiratory smooth muscle 176
Further studies at neuropeptide S position 5: Discovery of novel neuropeptide S receptor antagonists 176
Pharmacological characterisation of novel kinin B2 receptor ligands 171
Urotensin II stimulates plasma extravasation in mice via UT receptor activation 171
[Arg(14), Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies 168
Structure-activity study at positions 3 and 4 of human neuropeptide S. 164
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists 161
Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11) 158
Pharmacological profile of NOP receptors coupled with calcium signaling via the chimeric protein Gαqi5 158
Differential agonistic and antagonistic effects of the urotensin-II ligand SB-710411 at rodent and primate UT receptors 158
In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1 155
Synthesis and separation of the enantiomers of the neuropeptide S receptor antagonist (9R/S)-3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68). 153
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]neuropeptide S 153
Structure-activity relationship study on Tyr9 of urotensin-II(4-11): Identification of a partial agonist of the UT receptor 150
Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors 150
Comparative biochemical and pharmacological characterization of a novel, NOP receptor selective hexapeptide, Ac-RYYRIR-ol 148
Pharmacological profile of hemokinin 1: a novel member of the tachykinin family 146
Structure-activity relationship study on human urotensin II 146
In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen(5), DTrp(7), Dab(8)] urotensin II(4-11) (UFP-803) 144
The peptidic urotensin-II receptor ligand GSK248451 possesses less intrinsic activity than the low-efficacy partial agonists SB-710411 and urantide in native mammalian tissues and recombinant cell systems 134
Synthesis and Structure-Activity Relationships of (-)-cis-N-Normetazocine-Based LP1 Derivatives 111
null 94
null 87
Pharmacological profile and antiparkinsonian properties of the novel nociceptin/orphanin FQ receptor antagonist 1-[1-Cyclooctylmethyl-5-(1-hydroxy-1-methyl-ethyl)-1,2,3,6-tetrahydro-pyridin-4-yl]-3-ethyl-1,3-dihydro-benzoimidazol-2-one (GF-4). 84
Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68. 82
null 78
Synthesis and Structure–Activity Relationships of Triazaspirodecanone Derivatives as Nociceptin/Orphanin FQ Receptor Ligands 49
Totale 7.125
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.177
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 873
Totale 30.050
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021330 0 0 0 0 0 50 31 62 13 59 61 54
2021/2022456 17 52 54 5 31 14 31 26 13 41 41 131
2022/2023439 43 26 15 51 79 59 34 35 56 1 21 19
2023/2024266 21 32 15 8 8 59 11 21 3 4 16 68
2024/2025922 35 27 105 23 108 92 23 36 123 74 137 139
2025/20262.132 292 274 782 322 397 65 0 0 0 0 0 0
Totale 7.125